Skip to main content
Columbia University in the City of New York
Columbia University
Columbia | Technology Ventures

Main navigation expanded

  • For Inventors
  • For Industry
  • Search Available Technologies
  • Lab-to-Market
  • About CTV
  • Forms
  • News and Events
  • Media
  • Submit an Invention Report
  • Inventors' Guide
  • Develop Your Innovation
  • Start a Company
  • SBIR/STTR Funding Support
  • IP and Entrepreneurship Language for Grant Applications
  • Columbia Lab-to-Market Accelerator Network
  • Request a Material Transfer or Confidentiality Agreement
  • Review Inventor Policies
  • Executives in Residence
  • Funding Opportunities
  • Columbia Commercialization & Entrepreneurial Resources
  • Faculty Ambassadors
  • Search Available Technologies
  • Software Express Licenses
  • Columbia Startups
  • Collaborate With Columbia Researchers
  • Start the Licensing Process
  • Columbia Startup Fellows Program
  • Featured Startup Investment Opportunities
  • VC and Tech Transfer Template for an Early-Stage Life-Science Startup License
  • AI Technologies
  • Irving Cancer Drug Discovery Program
  • Technology Transfer at Columbia
  • A Virtuous Cycle
  • CTV Fellows Program
  • Meet Our Team
  • Careers
  • Invention Report Form
  • Material Transfer Agreement Forms
  • CDA/NDA Request Form
  • Sponsored Research Agreement
  • Faculty Handbook IP Policy
  • News
  • Events
    • CTV Innovation-to-Impact Series
  • Subscribe
  • Podcast
  • Videos
Columbia | Technology Ventures

You are here:

  1. Home
  2. News
  3. Leica Microsystems' new Viventis microscope debuts at Cell Bio 2025

Leica Microsystems' new Viventis microscope debuts at Cell Bio 2025

Leica Microsystems' new Viventis microscope debuted at Cell Bio 2025. The microscope uses SCAPE technology developed by Elizabeth Hillman, formerly of Columbia.

December 16, 2025

News

July 14, 2026

Activate Welcomes 50 New Fellows to Cohort 2026

July 06, 2026

Carbontech Development Initiative Announces Fourth and Final Cohort for Research and Commercialization Grants

June 23, 2026

AI Tool Developed at NewYork-Presbyterian and Columbia to Detect Hidden Heart Disease Receives FDA Approval

June 22, 2026

Doctors Thought It Was Asthma. A.I. Flagged a Serious Heart Problem.

June 12, 2026

Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1

Manhattanville Campus3280 Broadway, 2nd Floor · New York, NY 10027

Phone

212-854-8444
212-305-5198

Contact Us

[email protected]

Follow Us

Facebook Twitter
Columbia University Columbia University Logo
©2026 Columbia University Accessibility Nondiscrimination Careers Built using Columbia Sites